These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6345334)

  • 21. The low incidence of bacterial infections could be a protective factor against variceal bleeding per se in hemodynamic responders to propranolol.
    Senzolo M; Cholongitas E; Marelli L; Thalheimer U; Patch D; Burroughs AK
    Am J Gastroenterol; 2006 Oct; 101(10):2436-7. PubMed ID: 17032210
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effects of propranolol or nitroglycerin on azygos blood flow in patients with portal hypertension].
    Notsumata K
    Nihon Shokakibyo Gakkai Zasshi; 1986 Aug; 83(8):1489-97. PubMed ID: 3097355
    [No Abstract]   [Full Text] [Related]  

  • 23. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical treatment of portal hypertension and oesophageal varices.
    Cales P; Braillon A; Lebrec D
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1144. PubMed ID: 6414607
    [No Abstract]   [Full Text] [Related]  

  • 25. [New therapeutic possibilities of propranolol].
    Preobrazhenskiĭ DV
    Ter Arkh; 1984; 56(12):123-8. PubMed ID: 6084317
    [No Abstract]   [Full Text] [Related]  

  • 26. Betablocker, hepatic functions and confusion.
    Bhalla A
    J Assoc Physicians India; 1999 Feb; 47(2):254-5. PubMed ID: 10999112
    [No Abstract]   [Full Text] [Related]  

  • 27. [Medical therapy of portal hypertension].
    Trejo R
    Rev Gastroenterol Mex; 2006 Aug; 71 Suppl 1():118-9. PubMed ID: 17037795
    [No Abstract]   [Full Text] [Related]  

  • 28. Propranolol for primary and secondary prophylaxis of variceal bleeding in children with cirrhosis.
    Ozsoylu S; Koçak N; Demir H; Yüce A; Gürakan F; Ozen H
    Turk J Pediatr; 2000; 42(1):31-3. PubMed ID: 10731866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zhi-fuzi, a cardiotonic Chinese herb, a new medical treatment choice for portal hypertension?
    Lin JS; Chan CY; Yang C; Wang YH; Chiou HY; Su YC
    Exp Biol Med (Maywood); 2007 Apr; 232(4):557-64. PubMed ID: 17392492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological treatment of portal hypertension.
    Patch D; Burroughs AK
    Prog Liver Dis; 1995; 13():269-92. PubMed ID: 9224506
    [No Abstract]   [Full Text] [Related]  

  • 31. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
    De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S
    Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal use of propranolol in portal hypertension.
    Cales P
    Gastroenterol Clin Biol; 2005 Feb; 29(2):207-8. PubMed ID: 15803523
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk of hepatic encephalopathy in patients taking propranolol for portal hypertension.
    Reding P
    Lancet; 1982 Sep; 2(8297):550. PubMed ID: 6125697
    [No Abstract]   [Full Text] [Related]  

  • 34. Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity.
    Baik SK; Park DH; Kim MY; Choi YJ; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ
    J Gastroenterol; 2003; 38(12):1150-4. PubMed ID: 14714252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early propranolol administration does not prevent development of esophageal varices in cirrhotic rats.
    Alatsakis M; Ballas KD; Pavlidis TE; Psarras K; Rafailidis S; Tzioufa-Asimakopoulou V; Marakis GN; Sakantamis AK
    Eur Surg Res; 2009; 42(1):11-6. PubMed ID: 18971580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spironolactone and propranolol in the management of hypertension.
    Akbar fA; Pearce MY
    Br J Clin Pract; 1984 Mar; 38(3):110-4. PubMed ID: 6370284
    [No Abstract]   [Full Text] [Related]  

  • 37. [Portal hypertension: value of combination of nitrate derivatives and beta blockers for better prevention?].
    Oberti F; Calès P
    Gastroenterol Clin Biol; 1995 Mar; 19(3):328-31. PubMed ID: 7781957
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of propranolol and sclerotherapy in bleeding esophageal varices. A case report.
    Anderberg B; Andersson PA; Heuman R; Jansson L; Jorfeldt L; Rutberg H; Sjödahl R
    Acta Chir Scand; 1984; 150(1):109-11. PubMed ID: 6608197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of propranolol in the treatment of arterial hypertension in elderly patients].
    Halawa B
    Przegl Lek; 1984; 41(8):545-50. PubMed ID: 6393225
    [No Abstract]   [Full Text] [Related]  

  • 40. [Attempted explantation of pituitrin activity in portal hypertension].
    Orszulok J; Rosengarten H; Panasewicz J
    Pol Tyg Lek; 1966 Jun; 21(24):913-7. PubMed ID: 5965015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.